Brief: Cns Pharmaceuticals Files For Offer And Sale Of Up To 2.1 Mln Shares Of Common Stock By Lincoln Park Capital Fund - SEC Filing
25/09/2020 22:03
Sept 25 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS INC FILES FOR OFFER AND SALE OF UP TO
2.1
MILLION SHARES OF COMMON STOCK BY LINCOLN PARK CAPITAL FUND -
SEC FILING
Source text: https://bit.ly/3kU8SoV
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026